Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 37.97 | N/A |
| PEG Ratio (TTM) | -28.85 | N/A |
| P/S Ratio (TTM) | 1.81 | N/A |
| P/B Ratio (TTM) | 4.74 | N/A |
| P/FCF Ratio (TTM) | 27.98 | N/A |
| Price to 5YR AVG Earnings Ratio | 38.35 | N/A |
| Price to 5YR AVG FCF Ratio | 22.70 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.92% | N/A |
| ROE (TTM) | 12.08% | N/A |
| Net Profit Margin (TTM) | 4.78% | N/A |
| ROIC 5YR AVG | 12.30% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.90% | 106.62% | 75.49% |
| Revenue | 3.47% | 2.48% | 4.14% |
| Net Income | 1.72% | 105.15% | 74.52% |
| Cash Flow | 27.26% | 53.79% | 43.40% |
Health (58%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.42 | N/A |
| Quick Ratio (TTM) | 1.42 | N/A |
| D/E Ratio (TTM) | 0.62 | N/A |
| Interest Coverage (TTM) | 5.87 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.97 | N/A |
| LTL to 5YR AVG FCF | 3.68 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.44% | N/A |